Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction

Bone Marrow Transplantation volume 41, pages 677–686 (2008)Cite this article

Abstract

Veno-occlusive disease is among the most serious complications following hematopoietic stem cell transplantation. While hepatic veno-occlusive disease occurs more commonly, the pulmonary variant remains quite rare and often goes unrecognized antemortem. Endothelial damage may represent the pathophysiologic foundation of these clinical syndromes. Recent advances in the treatment of hepatic veno-occlusive disease may have application to its pulmonary counterpart.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Appelbaum FR . Hematopoietic-cell transplantation at 50. N Engl J Med 2004; 357: 1472–1475.

    Article  Google Scholar 

  2. Copelan EA . Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813–1826.

    Article  CAS  PubMed  Google Scholar 

  3. Woywodt A, Haubitz M, Buchholz S, Hertenstein B . Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation. Bone Marrow Transplant 2004; 34: 1015–1023.

    Article  CAS  PubMed  Google Scholar 

  4. Villalon L, Avello AG, Cesar J, Odriozola J, Lopez J, Oteyza JP et al. Is veno-occlusive disease a specific syndrome or the exacerbation of physiopathologic hemostatic changes in hematopoietic stem cell transplantation (HSCT)? Thromb Res 2000; 99: 439–446.

    Article  CAS  PubMed  Google Scholar 

  5. Uderzo C, Bonanomi S, Busca A, Renoldi M, Ferrari P, Iacobelli M et al. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Transplantation 2006; 82: 638–644.

    Article  PubMed  Google Scholar 

  6. Matute-Bello G, McDonald GD, Hinds MS, Schoch HG, Crawford SW . Association of pulmonary function testing abnormalities and severe veno-occlusive disease of the liver after marrow transplantation. Bone Marrow Transplant 1998; 21: 1125–1130.

    Article  CAS  PubMed  Google Scholar 

  7. Cooke KR, Yanik G . Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease? Bone Marrow Transplant 2004; 34: 753–765.

    Article  CAS  PubMed  Google Scholar 

  8. Gordon B, Lyden E, Lynch J, Tarantolo S, Pavletic ZS, Bishop M et al. Central nervous system dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients. Bone Marrow Transplant 2000; 25: 79–83.

    Article  CAS  PubMed  Google Scholar 

  9. Haire WD . Multiple organ dysfunction syndrome in hematopoietic stem cell transplantation. Crit Care Med 2002; 30 (5 Suppl): S257–S262.

    Article  PubMed  Google Scholar 

  10. Troussard X, Bernaudin JF, Cordonnier C, Fleury J, Payen D, Briere J et al. Pulmonary veno-occlusive disease after bone marrow transplantation. Thorax 1984; 39: 956–957.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Hackman RC, Madtes DK, Petersen FB, Clark JG . Pulmonary venoocclusive disease following bone marrow transplantation. Transplantation 1989; 47: 989–992.

    Article  CAS  PubMed  Google Scholar 

  12. Williams LM, Fussell S, Veith RW, Nelson S, Mason CM . Pulmonary veno-occlusive disease in an adult following bone marrow transplantation. Case report and review of the literature. Chest 1996; 109: 1388–1391.

    Article  CAS  PubMed  Google Scholar 

  13. Seguchi M, Hirabayashi N, Fujii Y, Azuno Y, Fujita N, Takeda K et al. Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation. Transplantation 2000; 69: 177–179.

    Article  CAS  PubMed  Google Scholar 

  14. Trobaugh-Lotrario AD, Greffe B, Deterding R, Deutsch G, Quinones R . Pulmonary veno-occlusive disease after autologous bone marrow transplant in a child with stage IV neuroblastoma: case report and literature review. J Pediatr Hematol Oncol 2003; 25: 405–409.

    Article  PubMed  Google Scholar 

  15. Mukai M, Kondo M, Bohgaki T, Notoya A, Kohno M . Pulmonary veno-occlusive disease following allogeneic peripheral blood stem cell transplantation for chronic myeloid leukaemia. Br J Haematol 2003; 123: 1.

    Article  PubMed  Google Scholar 

  16. Mandel J, Mark EJ, Hales CA . Pulmonary veno-occlusive disease. Am J Respir Crit Care Med 2000; 162: 1964–1973.

    Article  CAS  PubMed  Google Scholar 

  17. Kuga T, Kohda K, Hirayama Y, Matsumoto S, Nakazawa O, Ando M et al. Pulmonary veno-occlusive disease accompanied by microangiopathic hemolytic anemia 1 year after a second bone marrow transplantation for acute lymphoblastic leukemia. Int J Hematol 1996; 64: 143–150.

    Article  CAS  PubMed  Google Scholar 

  18. Salzman D, Adkins DR, Craig F, Freytes C, LeMaistre CF . Malignancy-associated pulmonary veno-occlusive disease: report of a case following autologous bone marrow transplantation and review. Bone Marrow Transplant 1996; 18: 755–760.

    CAS  PubMed  Google Scholar 

  19. Or R, Nagler A, Elad S, Naparstek E, Schechter D . Noncardiogenic pulmonary congestion following bone marrow transplantation. Respiration 1997; 64: 170–172.

    Article  CAS  PubMed  Google Scholar 

  20. Holcomb BW, Loyd JE, Ely EW, Johnson J, Robbins IM . Pulmonary veno-occlusive disease: a case series and new observations. Chest 2000; 118: 1671–1679.

    PubMed  Google Scholar 

  21. Veeraraghavan S, Koss MN, Sharma OP . Pulmonary veno-occlusive disease. Curr Opin Pulm Med 1999; 5: 310–313.

    Article  CAS  PubMed  Google Scholar 

  22. Lantuejoul S, Sheppard MN, Corrin B, Burke MM, Nicholson AG . Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases. Am J Surg Pathol 2006; 30: 850–857.

    Article  PubMed  Google Scholar 

  23. Hora J . Zur histologie der klinischen ‘primaren Pulmonalsklerose’. Frankf Z Pathol 1934; 47: 100.

    Google Scholar 

  24. Heath D, Segel N, Bishop J . Pulmonary veno-occlusive disease. Circulation 1966; 34: 242–248.

    Article  CAS  PubMed  Google Scholar 

  25. Nunes H, Humbert M, Capron F, Brauner M, Sitbon O, Battesti JP et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 2006; 61: 68–74.

    Article  CAS  PubMed  Google Scholar 

  26. Johnson SR, Patsios D, Hwang DM, Granton JT . Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension. J Rheumatol 2006; 33: 2347–2350.

    PubMed  Google Scholar 

  27. Zhang L, Visscher D, Rihal C, Aubry MC . Pulmonary veno-occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease. Rheumatol Int 2007; 27: 1163–1165.

    Article  PubMed  Google Scholar 

  28. Shahab N, Haider S, Doll DC . Vascular toxicity of antineoplastic agents. Semin Oncol 2006; 33: 121–138.

    Article  CAS  PubMed  Google Scholar 

  29. Saito A, Takizawa H, Ito K, Yamamoto K, Oka T . A case of pulmonary veno-occlusive disease associated with systemic sclerosis. Respirology 2003; 8: 383–385.

    Article  PubMed  Google Scholar 

  30. Voordes CG, Kuipers JR, Elema JD . Familial pulmonary veno-occlusive disease: a case report. Thorax 1977; 32: 763–766.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Davies P, Reid L . Pulmonary veno-occlusive disease in siblings: case reports and morphometric study. Hum Pathol 1982; 13: 911–915.

    Article  CAS  PubMed  Google Scholar 

  32. Runo JR, Vnencak-Jones CL, Prince M, Loyd JE, Wheeler L, Robbins IM et al. Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. Am J Respir Crit Care Med 2003; 167: 889–894.

    Article  PubMed  Google Scholar 

  33. Kufe DW, Frei III E, Holland JF, Weichselbaum RR, Pollock RE, Bast RC et al. Holland-Frei Cancer Medicine, 7th edn. BC Decker Inc.: Columbia, 2006.

    Google Scholar 

  34. Takatsuka H, Wakae T, Mori A, Okada M, Okamoto T, Kakishita E . Effects of total body irradiation on the vascular endothelium. Clin Transplant 2002; 16: 374–377.

    Article  PubMed  Google Scholar 

  35. Soubani AO, Miller KB, Hassoun PM . Pulmonary complications of bone marrow transplantation. Chest 1996; 109: 1066–1077.

    Article  CAS  PubMed  Google Scholar 

  36. Kotloff RM, Ahya VN, Crawford SW . Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2004; 170: 22–48.

    Article  PubMed  Google Scholar 

  37. Roychowdhury M, Pambuccian SE, Aslan DL, Jessurun J, Rose AG, Manivel JC et al. Pulmonary complications after bone marrow transplantation: an autopsy study from a large transplantation center. Arch Pathol Lab Med 2005; 129: 366–371.

    Article  PubMed  Google Scholar 

  38. Camus P, Costabel U . Drug-induced respiratory disease in patients with hematological diseases. Semin Respir Crit Care Med 2005; 26: 458–481.

    Article  PubMed  Google Scholar 

  39. Wagenvoort CA, Wagenvoort N, Takahashi T . Pulmonary veno-occlusive disease: involvement of pulmonary arteries and review of the literature. Hum Pathol 1985; 16: 1033–1041.

    Article  CAS  PubMed  Google Scholar 

  40. Malhotra P, Varma S, Varma N, Sharma RR, Jain S, Kumari S et al. Pulmonary veno-occlusive disease as a cause for reversible pulmonary hypertension in a patient with multiple myeloma undergoing peripheral blood stem cell transplantation. Am J Hematol 2005; 80: 164–165.

    Article  PubMed  Google Scholar 

  41. Frazier AA, Franks TJ, Mohammed TL, Ozbudak IH, Galvin JR . From the archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis. Radiographics 2007; 27: 867–882.

    Article  PubMed  Google Scholar 

  42. Ware LB, Matthay MA . The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334–1349.

    Article  CAS  PubMed  Google Scholar 

  43. Rambihar VS, Fallen EL, Cairns JA . Pulmonary veno-occlusive disease: antemortem diagnosis from roentgenographic and hemodynamic findings. Can Med Assoc J 1979; 120: 1519–1522.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Weed HG . Pulmonary ‘capillary’ wedge pressure not the pressure in the pulmonary capillaries. Chest 1991; 100: 1138–1140.

    Article  CAS  PubMed  Google Scholar 

  45. Almagro P, Alvarez M, Garau J . Lung biopsy in pulmonary veno-occlusive disease. Chest 2001; 120: 1421–1422.

    Article  CAS  PubMed  Google Scholar 

  46. Drexler H, Hornig B . Endothelial dysfunction in human disease. J Mol Cell Cardiol 1999; 31: 51–60.

    Article  CAS  PubMed  Google Scholar 

  47. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91: 3527–3561.

    CAS  PubMed  Google Scholar 

  48. Catani L, Gugliotta L, Vianelli N, Nocentini F, Baravelli S, Bandini G et al. Endothelium and bone marrow transplantation. Bone Marrow Transplant 1996; 17: 277–280.

    CAS  PubMed  Google Scholar 

  49. Testa S, Manna A, Porcellini A, Maffi F, Morstabilini G, Denti N et al. Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation. Bone Marrow Transplant 1996; 18: 383–388.

    CAS  PubMed  Google Scholar 

  50. Richardson PG, Elias AD, Krishnan A, Wheeler C, Nath R, Hoppensteadt D et al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood 1998; 92: 737–744.

    CAS  PubMed  Google Scholar 

  51. Chopra R, Eaton JD, Grassi A, Potter M, Shaw B, Salat C et al. Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. Br J Haematol 2000; 111: 1122–1129.

    CAS  PubMed  Google Scholar 

  52. Salat C, Holler E, Kolb HJ, Reinhardt B, Pihusch R, Wilmanns W et al. Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation. Blood 1997; 89: 2184–2188.

    Article  CAS  PubMed  Google Scholar 

  53. Richardson PG, Hoppensteadt D, Elias AD, Frei E, Iacobelli M, Guinan E et al. Elevation of tissue factor pathway inhibitor (TFPI), thrombomodulin (TM), and plasminogen activator inhibitor-1 (PAI-1) levels in stem cell transplant associated veno-occlusive disease and changes with the use of defibrotide. Blood 1997; 90: 219a.

    Google Scholar 

  54. Richardson PG, Krishnan A, Wheeler C, Hoppensteadt D, Tuchin J, Fyfe H et al. Elevation of PAI-1 levels in BMT associated VOD and changes seen in the use of Defibrotide. Blood 1996; 88: 458a.

    Google Scholar 

  55. Lahm T, Crisostomo PR, Markel TA, Wang M, Lillemoe KD, Meldrum DR . The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury. Shock 2007; 28: 4–14.

    Article  CAS  PubMed  Google Scholar 

  56. Iguchi A, Kobayashi R, Yoshida M, Kobayashi K, Matsuo K, Kitajima I et al. Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation. Bone Marrow Transplant 2001; 27: 1173–1180.

    Article  CAS  PubMed  Google Scholar 

  57. Barst RJ . PDGF signaling in pulmonary arterial hypertension. J Clin Invest 2005; 115: 2691–2694.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Assaad AM, Kawut SM, Arcasoy SM, Rosenzweig EB, Wilt JS, Sonett JR et al. Platelet-derived growth factor is increased in pulmonary capillary hemangiomatosis. Chest 2007; 131: 850–855.

    Article  PubMed  Google Scholar 

  59. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255–267.

    Article  CAS  PubMed  Google Scholar 

  60. Wadleigh M, Ho V, Momtaz P, Richardson P . Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment. Curr Opin Hematol 2003; 10: 451–462.

    Article  PubMed  Google Scholar 

  61. Kumar S, DeLeve LD, Kamath PS, Tefferi A . Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc 2003; 78: 589–598.

    Article  PubMed  Google Scholar 

  62. Kalayoglu-Besisik S, Yenerel MN, Caliskan Y, Ozturk S, Besisik F, Sargin D . Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years. Transplant Proc 2005; 37: 2285–2289.

    Article  CAS  PubMed  Google Scholar 

  63. Cesaro S, Pillon M, Talenti E, Toffolutti T, Calore E, Tridello G et al. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Haematologica 2005; 90: 1396–1404.

    PubMed  Google Scholar 

  64. Falanga A, Vignoli A, Marchetti M, Barbui T . Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells. Leukemia 2003; 17: 1636–1642.

    Article  CAS  PubMed  Google Scholar 

  65. Kuroki I, Miyazaki T, Mizukami I, Matsumoto N, Matsumoto I . Effect of sodium nitroprusside on ischemia-reperfusion injuries of the rat liver. Hepatogastroenterology 2004; 51: 1404–1407.

    CAS  PubMed  Google Scholar 

  66. Kaleelrahman M, Eaton JD, Leeming D, Bowyer K, Taberner D, Chang J et al. Role of plasminogen activator inhibitor-1 (PAI-1) levels in the diagnosis of BMT-associated hepatic veno-occlusive disease and monitoring of subsequent therapy with defibrotide (DF). Hematology 2003; 8: 91–95.

    Article  CAS  PubMed  Google Scholar 

  67. Izbicki G, Shitrit D, Schechtman I, Bendayan D, Fink G, Sahar G et al. Recurrence of pulmonary veno-occlusive disease after heart-lung transplantation. J Heart Lung Transplant 2005; 24: 635–637.

    Article  PubMed  Google Scholar 

  68. Liu C, Chen J . Endothelin receptor antagonists for pulmonary arterial hypertension. Cochrane Database Systematic Reviews 2005; Issue 1, Art No.: CD004434 (doi:10.1002/14651858.CD004434.pub3).

  69. Hoeper MM, Eschenbruch C, Zink-Wohlfart C, Schulz A, Markworth S, Pohl K et al. Effects of inhaled nitric oxide and aerosolized iloprost in pulmonary veno-occlusive disease. Respir Med 1999; 93: 62–64.

    Article  CAS  PubMed  Google Scholar 

  70. Palevsky HI, Pietra GG, Fishman AP . Pulmonary veno-occlusive disease and its response to vasodilator agents. Am Rev Respir Dis 1990; 142: 426–429.

    Article  CAS  PubMed  Google Scholar 

  71. Kuroda T, Hirota H, Masaki M, Sugiyama S, Oshima Y, Terai K et al. Sildenafil as adjunct therapy to high-dose epoprostenol in a patient with pulmonary veno-occlusive disease. Heart Lung Circ 2006; 15: 139–142.

    Article  PubMed  Google Scholar 

  72. Palmer SM, Robinson LJ, Wang A, Gossage JR, Bashore T, Tapson VF . Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. Chest 1998; 113: 237–240.

    Article  CAS  PubMed  Google Scholar 

  73. Okumura H, Nagaya N, Kyotani S, Sakamaki F, Nakanishi N, Fukuhara S et al. Effects of continuous IV prostacyclin in a patient with pulmonary veno-occlusive disease. Chest 2002; 122: 1096–1098.

    Article  PubMed  Google Scholar 

  74. Salzman GA, Rosa UW . Prolonged survival in pulmonary veno-occlusive disease treated with nifedipine. Chest 1989; 95: 1154–1156.

    Article  CAS  PubMed  Google Scholar 

  75. Gilroy Jr RJ, Teague MW, Loyd JE . Pulmonary veno-occlusive disease. Fatal progression of pulmonary hypertension despite steroid-induced remission of interstitial pneumonitis. Am Rev Respir Dis 1991; 143 (5 Part 1): 1130–1133.

    Article  PubMed  Google Scholar 

  76. Johnson SR, Granton JT, Mehta S . Thrombotic arteriopathy and anticoagulation in pulmonary hypertension. Chest 2006; 130: 545–552.

    Article  CAS  PubMed  Google Scholar 

  77. Eissner G, Iacobelli M, Bluml S, Burger V, Haffner S, Andreesen R et al. Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity. Bone Marrow Transplant 2005; 35: 915–920.

    Article  CAS  PubMed  Google Scholar 

  78. Haussmann U, Fischer J, Eber S, Scherer F, Seger R, Gungor T . Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy. Haematologica 2006; 91: 795–800.

    PubMed  Google Scholar 

  79. Ringden O, Remberger M, Lehmann S, Hentschke P, Mattsson J, Klaesson S et al. N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation. Bone Marrow Transplant 2000; 25: 993–996.

    Article  CAS  PubMed  Google Scholar 

  80. Bearman SI . Avoiding hepatic veno-occlusive disease: what do we know and where are we going? Bone Marrow Transplant 2001; 27: 1113–1120.

    Article  CAS  PubMed  Google Scholar 

  81. Kelly GS . Clinical applications of N-acetylcysteine. Altern Med Rev 1998; 3: 114–127.

    CAS  PubMed  Google Scholar 

  82. Raunio H, Hakkola J, Hukkanen J, Lassila A, Paivarinta K, Pelkonen O et al. Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue. Exp Toxicol Pathol 1999; 51: 412–417.

    Article  CAS  PubMed  Google Scholar 

  83. Kehrer JP . Bleomycin and cyclophosphamide toxicity in mice with damaged lung tissue. Toxicology 1989; 57: 69–82.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Minnesota, Minneapolis, MN, USA

    M C Bunte, M M Patnaik, M R Pritzker & L J Burns

  2. Division of Cardiology, University of Minnesota, Minneapolis, MN, USA

    M R Pritzker

  3. Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA

    L J Burns

Authors
  1. M C Bunte
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M M Patnaik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M R Pritzker
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L J Burns
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L J Burns.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bunte, M., Patnaik, M., Pritzker, M. et al. Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction. Bone Marrow Transplant 41, 677–686 (2008). https://doi.org/10.1038/sj.bmt.1705990

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705990

Keywords

This article is cited by

Search

Advanced search

Quick links